COVID-19

Testing Solutions

The SORFA® Sampling System is a Nasal Swab Sample Collection Kit. This system is a reliable solution for the collection and long-term frozen storage of viruses, including COVID-19. The system has been registered with the U.S. FDA and assigned Regulation Number 864.3250.

• Reliable solution for the collection and long-term frozen storage of viruses, including COVID-19.
• Superior leak-proof tubes with conical bottom, ideal for centrifugation.
• Available in 2ml or 3ml media volumes.
• Nasopharyngeal swab with flocked tip is easily fractured and included with transport media.
• Two beads in each tube designed for rapid specimen release and dispersion.
• Ergonomic design of swab conforms to facial structure of different people to deliver safe and efficient sampling.
• 50 sterile nasal swabs and viral transport media in each kit.

Helpful Resources:

FAQs on Viral Transport Media During COVID-19

Sample Collection Video Link

PrimeStore® Molecular Transport Medium (MTM) received FDA clearance in March 2018 as a De Novo Class II microbial nucleic acid storage and stabilization device. PrimeStore® MTM is the first molecular transport device designed to inactivate pathogens at the point of collection and stabilize both RNA and DNA for downstream molecular testing and characterization outside of containment equipment/facilities. Its ability to safely transport RNA and DNA at ambient temperatures saves significant cost and infrastructure associated with eliminating the cold chain. It has been validated for coronavirus screening with multiple published peer reviewed studies and is proven to inactivate SARS-CoV-2. PrimeStore® MTM is listed on the FDA “preferred transport media” list for COVID-19.

• Received FDA Clearance as a De Novo Class II microbial nucleic acid storage and stabilization device under 21 CFR 866.2950.
• Listed on the FDA “preferred transport media” list for COVID-19.
• Inactivates viral and bacterial pathogens from samples placed in the collection tube for improved user safety during laboratory handling.
• Stored and transported at ambient temperature; eliminates cold chain logistics.
• Works with the following collection samples: sputum, saliva, swabs (oral, throat, nasal, nasopharyngeal, buccal), blood/plasma/serum, nasal washes, urine, other body fluids.
• 50 tubes per box; available in 5ml, 4ml or 3ml test tube sizes with 1.5ml of media.

Helpful Resources:

FDA Letter

FDA Decision Summary

FAQs on Viral Transport Media During COVID-19

The iSWAB Microbiome is a Microbial Inactivation and Nucleic Acid Collection and Stabilization Device for the safe and reliable collection and transport of viral RNA samples at room temperature during the COVID-19 pandemic.  Using a proprietary formula, the iSWAB media inactivates live viral and bacterial pathogens in the collection tube for improved user safety during transportation, handling, and sample processing.  The media is “non-toxic” and does not contain organic solvents, guanidine salts or guanidine-like chemicals eliminating the potential risk of toxic gases being released during cleaning procedures. 

A funnel-shaped component with small “teeth” in the collection tube enables complete release of collected material from any swab type, including flocked swabs without the need to break off the swab tip in tube, reducing the potential for leachables contaminating the sample and streamlining the sample processing step.  The 1.0ml volume concentrates the sample while the media deactivates degradative enzymes that can reduce the quality of the sample, which can affect RNA extraction and amplification.  Viral RNA samples can remain stable in the iSWAB Microbiome at ambient temperature for up to 21 days, addressing cold-chain shipping logistics and testing bottlenecks at molecular labs.

• iSWAB is registered with the U.S. FDA and assigned Regulation Number 864.3250.
• Inactivates viral and bacterial pathogens from samples placed in the collection tube for improved user safety during laboratory handling.
• Stored and transported at ambient temperature; eliminates cold chain logistics.
• Media is “non-toxic” and does not contain organic solvents, guanidine salts or guanidine-like chemicals eliminating the potential risk of toxic gases being released during cleaning procedures.
• Works with the following collection samples: sputum, saliva, swabs (oral, throat, nasal, nasopharyngeal, buccal), blood/plasma/serum, nasal washes, urine, other body fluids.
• 500 tubes per box; available in a 2ml test tube size with 1ml of media

Helpful Resources:

FAQs on Viral Transport Media During COVID-19

How iSWAB Technology Works

Media Coverage Using iSWAB

Spartan Medical® offers a complete line of Flocking Nylon Viral Transport Swabs for the collection of samples for SARS-CoV-2. Swabs are provided sterile and have FDA Regulation #: 2007US314518, Registration Establishment #: 10072745. Test samples are collected via the nasal passage and/or back of throat. Once collection is completed, swab tip is broken at score point and included with transport media to preserves sample and minimize bacterial overgrowth from time of collection to the actual testing of the sample.

• Nasopharyngeal Swab – 20mm swab length, 3mm width, 80mm from tip to break point.
• Oropharyngeal Swab – 20mm swab length, 5mm width, 30mm from tip to break point.
• Throat Swabs – 20mm swab length, 4mm width, 80mm from tip to break point.
• 5000 Sterile Nasopharyngeal or Oropharyngeal or Throat Swabs in each in box (100 swabs per bag/ 50 bags per box).

Helpful Resources:

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Sample Collection Video Link